Reduced LAMA2 expression in hepatocellular carcinomas has been linked to a proliferative signature with poorer survival outcomes; hypermethylation of LAMA2 has also been reported in colorectal carcinomas 24, 25. The gene discussed is LAMA2; the disease is colorectal carcinoma.